SABIC, a global leader in the chemical industry, is showcasing here at NPE 2018, booth S19001, the success of its collaborative efforts with customer, eNeura Inc. (“eNeura”), in developing a clinically proven, non-drug option for the prevention and treatment of migraine headaches. The sTMS mini® by eNeura® is a physician-prescribed, portable delivery system for single-pulse, transcranial magnetic stimulation. Working with SABIC and PTA Plastics, its injection molder, eNeura selected SABIC’s LEXAN™ polycarbonate (PC) copolymer for the housing of the device. This healthcare-grade material met the company’s stringent requirements for biocompatibility, resistance to impact and household chemicals, light weight for easy handling, and the ability to be precisely color matched. The sTMS mini was cleared by the U.S. Food and Drug Administration for migraine prevention in 2017, following previous agency clearance in 2014 for acute treatment.
Log in to view full press release.